Adjunct methods of the standard diabetic foot ulceration therapy

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Waniczek, Dariusz ^a   Kozowicz, Andrzej ^a   Muc Wierzgoń, Małgorzata ^a   Kokot, Teresa ^a   Świȩtochowska, Elzbieta ^a   Nowakowska Zajdel, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBRIN; FIBRONECTIN; OSTEOCALCIN; OSTEONECTIN; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN; VITRONECTIN;

AMPUTATION; CAPILLARY FLOW; CELL ADHESION; CELL DIFFERENTIATION; CENTRIFUGATION; CHEMOTAXIS; CLAUSTROPHOBIA; CLINICAL TRIAL (TOPIC); DEBRIDEMENT; DIABETIC FOOT; EAR INJURY; HUMAN; HYPERBARIC CHAMBER; HYPERBARIC OXYGEN; INFLAMMATION; INTRACELLULAR SIGNALING; LEUKOCYTE; LEUKOCYTE AGGREGATION; LUNG INJURY; MACROPHAGE; MAGGOT; MAGGOT THERAPY; MONOCYTE; MORBIDITY; NEUTROPHIL; OXYGEN DIFFUSION; OXYGEN TENSION; PATHOGENESIS; PHAGOCYTOSIS; PLATELET RICH PLASMA THERAPY; PRIORITY JOURNAL; REVIEW; RISK; THERAPY EFFECT; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; WOUND CARE; WOUND HEALING;

EID: 84880152650     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/243568     Document Type: Review

References (110)

1. IDF Diabetes Atlas 2012 5th
2. Bruhn-Olszewska B., Korzon-Burakowska A., Gabig-Cimińska M., Olszewski P., Wegrzyn A., Jakóbkiewicz-Banecka J., Molecular factors involved in the development of diabetic foot syndrome. Acta Biochimica Polonica 2012 59 4 507 513
3. Cornell S., Dorsey V. J., Diabetes pharmacotherapy in 2012: considerations in medication selection. Postgraduate Medicine 2012 124 84 94 10.3810/pgm.2012.07.2571
4. Iversen M. M., An Epidemiologic Study of Diabetes-Related Foot Ulcers 2009 Bergen, Norway Department of Public Health and Primary Health Care
5. Brem H., Sheehan P., Boulton A. J. M., Protocol for treatment of diabetic foot ulcers. The American Journal of Surgery 2004 187 5 1 10 2-s2.0-2442513339 10.1016/S0002-9610(03)00299-X (Pubitemid 38625981)
6. Krishnan S., Nash F., Baker N., Fowler D., Rayman G., Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008 31 1 99 101 2-s2.0-38149042004 10.2337/dc07-1178
7. Bolton L., McNees P., van Rijswijk L., de Leon J., Lyder C., Kobza L., Edman K., Scheurich A., Shannon R., Toth M., Wound-healing outcomes using standardized assessment and care in clinical practice. Journal of Wound, Ostomy, and Continence Nursing 2004 31 2 65 71 2-s2.0-3042725350
8. Boulton A. J. M., Cavanagh P. R., Rayman G., The Foot in Diabetes 2006 4th New York, NY, USA John Wiley & Sons
9. Singh N., Armstrong D. G., Lipsky B. A., Preventing foot ulcers in patients with diabetes. The Journal of the American Medical Association 2005 293 2 217 228 2-s2.0-11844293372 10.1001/jama.293.2.217 (Pubitemid 40095873)
10. Boulton A. J. M., The pathogenesis of diabetic foot problems: an overview. Diabetic Medicine 1996 13 1 S12 S16 2-s2.0-0030047834
11. Ndip A., Jude E. B., Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice. International Journal of Lower Extremity Wounds 2009 8 2 82 94 2-s2.0-65649153382 10.1177/1534734609336948
12. Ribu L., Hanestad B. R., Moum T., Birkeland K., Rustoen T., A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Quality of Life Research 2007 16 2 179 189 2-s2.0-33846152913 10.1007/s11136-006-0031-y (Pubitemid 46088352)
13. Ramsey S. D., Newton K., Blough D., McCulloch D. K., Sandhu N., Reiber G. E., Wagner E. H., Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999 22 3 382 387 2-s2.0-0033016846 (Pubitemid 29106890)
14. Bakker K., Apelqvist J., Schaper N. C., Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes/Metabolism Research and Reviews 2012 28 1 225 231 2-s2.0-84856185057 10.1002/dmrr.2253
15. Wagner F. W. Jr., The dysvascular foot: a system for diagnosis and treatment. Foot and Ankle 1981 2 2 64 122 2-s2.0-0019803407 (Pubitemid 12170741)
16. Lavery L. A., Effectiveness and safety of elective surgical procedures to improve wound healing and reduce re-ulceration in diabetic patients with foot ulcers. Diabetes/Metabolism Research and Reviews 2012 28 1 60 63 2-s2.0-84856203369 10.1002/dmrr.2241
17. Baroni G., Porro T., Faglia E., Pizzi G., Mastropasqua A., Oriani G., Pedesini G., Favales F., Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 1987 10 1 81 86 2-s2.0-0023198225 (Pubitemid 17069073)
18. Zamboni W. A., Wong H. P., Stephenson L. L., Pfeifer M. A., Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea and Hyperbaric Medicine 1997 24 3 175 179 2-s2.0-0031225293 (Pubitemid 127460661)
19. Faglia E., Favales F., Aldeghi A., Calia P., Quarantiello A., Barbano P., Puttini M., Palmieri B., Brambilla G., Rampoldi A., Mazzola E., Valenti L., Fattori G., Rega V., Cristalli A., Oriani G., Michael M., Morabito A., Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. Journal of Diabetes and Its Complications 1998 12 2 96 102 2-s2.0-0031981962 10.1016/S1056-8727(97)98004-1 (Pubitemid 28156439)
20. Faglia E., Favales F., Aldeghi A., Calia P., Quarantiello A., Oriani G., Michael M., Campagnoli P., Morabito A., Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diabetes Care 1996 19 12 1338 1343 2-s2.0-0029912701 (Pubitemid 26418611)
21. Thom S. R., Hyperbaric oxygen: its mechanisms and efficacy. Plastic and Reconstructive Surgery 2011 127 1 131 141 10.1097/PRS.0b013e3181fad328
22. Feldmeier J. J., Hampson N. B., A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea and hyperbaric Medicine 2002 29 1 4 30
23. Niinikoski J. H. A., Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry. World Journal of Surgery 2004 28 3 307 311 2-s2.0-1642415178 10.1007/s00268-003-7401-1 (Pubitemid 38375534)
24. Ackerman N. B., Brinkley F. B., Oxygen tensions in normal and ischemic tissues during hyperbaric therapy. Studies in rabbits. The Journal of the American Medical Association 1966 198 12 1280 1283 2-s2.0-0014022406 10.1001/jama.198.12.1280
25. Löndahl M., Katzman P., Hammarlund C., Nilsson A., Landin-Olsson M., Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers. Diabetologia 2011 54 1 65 68 2-s2.0-79953786825 10.1007/s00125-010-1946-y
26. Heinzelmann M., Scott M., Lam T., Factors predisposing to bacterial invasion and infection. The American Journal of Surgery 2002 183 2 179 190 2-s2.0-0036128529 10.1016/S0002-9610(01)00866-2 (Pubitemid 34246432)
27. Mader J. T., Brown G. L., Guckian J. C., Wells C. H., Reinarz J. A., A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. Journal of Infectious Diseases 1980 142 6 915 922 2-s2.0-0019257460 (Pubitemid 11153260)
28. Heng M. C., Harker J., Csathy G., Marshall C., Brazier J., Sumampong S., Gomez E. P., Angiogenesis in necrotic ulcers treated with hyperbaric oxygen. Ostomy/Wound Management 2000 46 9 18 32 2-s2.0-0034279777
29. Thom S. R., Milovanova T. N., Yang M., Bhopale V. M., Sorokina E. M., Uzun G., Malay D. S., Troiano M. A., Hardy K. R., Lambert D. S., Logue C. J., Margolis D. J., Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: Increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy. Wound Repair and Regeneration 2011 19 2 149 161 2-s2.0-79952274539 10.1111/j.1524-475X.2010.00660.x
30. Ramon Y., Abramovich A., Shupak A., Ullmann Y., Moscona R. A., Shoshani O., Peled I. J., Effect of hyperbaric oxygen on a rat transverse rectus abdominis myocutaneous flap model. Plastic and Reconstructive Surgery 1998 102 2 416 422 2-s2.0-0031815208 10.1097/00006534-199808000-00019 (Pubitemid 28366666)
31. Selçuk C. T., Kuvat S. V., Bozkurt M., Yaşar Z., Gülsün N., Ilgezdi S., Ula M., Ozalp B., The effect of hyperbaric oxygen therapy on the survival of random pattern skin flaps in nicotine-treated rats. Journal of Plastic, Reconstructive and Aesthetic Surgery 2012 65 4 489 493 10.1016/j.bjps.2011.11.015
32. Kranke P., Bennett M., Roeckl-Wiedmann I., Debus S. E., Hyperbaric oxygen therapy for chronic wounds. Cochrane Database of Systematic Reviews 2004 2 CD004123 2-s2.0-3843130887
33. Löndahl M., Katzman P., Nilsson A., Hammarlund C., Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010 33 5 998 1003 2-s2.0-77954915401 10.2337/dc09-1754
34. Duzgun A. P., Satir H. Z., Ozozan O., Saylam B., Kulah B., Coskun F., Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. Journal of Foot and Ankle Surgery 2008 47 6 515 519 2-s2.0-54849415887 10.1053/j.jfas.2008.08.002
35. Abidia A., Laden G., Kuhan G., Johnson B. F., Wilkinson A. R., Renwick P. M., Masson E. A., McCollum P. T., The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomized-controlled trial. European Journal of Vascular and Endovascular Surgery 2003 25 6 513 518 2-s2.0-0038510887 10.1053/ejvs.2002.1911 (Pubitemid 36701789)
36. Kalani M., Jörneskog G., Naderi N., Lind F., Brismar K., Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers-long-term follow-up. Journal of Diabetes and Its Complications 2002 16 2 153 158 2-s2.0-0036125661 10.1016/S1056-8727(01)00182-9 (Pubitemid 34224118)
37. Doctor N., Pandya S., Supe A., Hyperbaric oxygen therapy in diabetic foot. Journal of Postgraduate Medicine 1992 38 3 112 111 2-s2.0-18544404545
38. Oriani G., Meazza D., Favales F., Hyperbaric oxygen in diabetic gangrene. Journal of Hyperbaric Medicine 1990 5 171 175
39. Hammarlund C., Sundberg T., Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plastic and Reconstructive Surgery 1994 93 4 829 833 2-s2.0-0028197029
40. Lyon K. C., The case for evidence in wound care: investigating advanced treatment modalities in healing chronic diabetic lower extremity wounds. Journal of Wound Ostomy and Continence Nursing 2008 35 6 585 590
41. Wunderlich R. P., Peters E. J. G., Lavery L. A., Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabetes Care 2000 23 10 1551 1555 2-s2.0-0033798712
42. Prete P. E., Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sciences 1997 60 8 505 510 2-s2.0-0031575417 10.1016/S0024-3205(96)00688-1 (Pubitemid 27099797)
43. Gupta A., A review of the use of maggots in wound therapy. Annals of Plastic Surgery 2008 60 2 224 227 10.1097/SAP.0b013e318053eb5e (Pubitemid 351158724)
44. Jarczyk G., Jackowski M., Szpila K., Boszek G., Kapelaty S., Use of Lucilia sericata blowfly maggots in the treatment of diabetic feet threatened with amputation. Acta Angiologica 2008 14 2 42 55 2-s2.0-58149479412
45. Sherman R. A., Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 2003 26 2 446 451 2-s2.0-0041308244 10.2337/diacare.26.2.446 (Pubitemid 36929071)
46. Armstrong D. G., Salas P., Short B., Martin B. R., Kimbriel H. R., Nixon B. P., Boulton A. J. M., Maggot therapy in "lower-extremity hospice" wound care: fewer amputations and more antibiotic-free days. Journal of the American Podiatric Medical Association 2005 95 3 254 257 2-s2.0-20444368845 (Pubitemid 40799780)
47. Bowling F. L., Salgami E. V., Boulton A. J. M., Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care 2007 30 2 370 371 2-s2.0-33846671131 10.2337/dc06-2348 (Pubitemid 46198348)
48. Chan D. C. W., Fong D. H. F., Leung J. Y. Y., Patil N. G., Leung G. K. K., Maggot debridement therapy in chronic wound care. Hong Kong Medical Journal 2007 13 5 382 386 2-s2.0-35548958300 (Pubitemid 350007036)
49. Game F. L., Hinchliffe R. J., Apelqvist J., Armstrong D. G., Bakker K., Hartemann A., Löndahl M., Price P. E., Jeffcoate W. J., A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes/Metabolism Research and Reviews 2012 28 1 119 141 2-s2.0-84856157787 10.1002/dmrr.2246
50. Ross R., Glomset J., Kariya B., Harker L., A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proceedings of the National Academy of Sciences of the United States of America 1974 71 4 1207 1210 2-s2.0-1842280753
51. Cenni E., Ciapetti G., Pagani S., Perut F., Giunti A., Baldini N., Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. Journal of Periodontology 2005 76 3 323 328 2-s2.0-18744395197 10.1902/jop.2005.76.3.323 (Pubitemid 40668375)
52. Kark L. R., Karp J. M., Davies J. E., Platelet releasate increases the proliferation and migration of bone marrow-derived cells cultured under osteogenic conditions. Clinical Oral Implants Research 2006 17 3 321 327 2-s2.0-33646509169 10.1111/j.1600-0501.2005.01189.x (Pubitemid 43709400)
53. Borzini P., Mazzucco I., Platelet-rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biologic view point? ISBT Science Series 2007 2 1 272 281 10.1111/j.1751-2824.2007.00085.x
54. Knighton D. R., Ciresi K. F., Fiegel V. D., Austin L. L., Butler E. L., Classification and treatment of chronic nonhealing wounds: successful treatment with autologous platelet-derived wound healing factors (PDWHF). Annals of Surgery 1986 204 3 322 330 2-s2.0-0022530730 (Pubitemid 16014252)
55. Pietramaggiori G., Scherer S. S., Mathews J. C., Alperovich M., Yang H., Neuwalder J., Czeczuga J. M., Chan R. K., Wagner C. T., Orgill D. P., Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair and Regeneration 2008 16 2 218 225 2-s2.0-40349116487 10.1111/j.1524-475X.2008.00362.x (Pubitemid 351342131)
56. Knighton D. R., Hunt T. K., Thakral K. K., Goodson W. H. III, Role of platelets and fibrin in the healing sequence. An in vivo study of angiogenesis and collagen synthesis. Annals of Surgery 1982 196 4 379 388 2-s2.0-0019976593 (Pubitemid 12030715)
57. Krupski W. C., Reilly L. M., Perez S., Moss K. M., Crombleholme P. A., Rapp J. H., A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. Journal of Vascular Surgery 1991 14 4 526 536 2-s2.0-0026000441 10.1067/mva.1991.31288
58. Margolis D. J., Kantor J., Santanna J., Strom B. L., Berlin J. A., Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001 24 3 483 488 2-s2.0-0035092184 (Pubitemid 32198417)
59. McAleer J. P., Sharma S., Kaplan E. M., Persich G., Use of autologous platelet concentrate in a nonhealing lower extremity wound. Advances in Skin & Wound Care 2006 19 7 354 363 2-s2.0-34948860161 10.1097/00129334- 200609000-00010
60. Driver V. R., Hanft J., Fylling C. P., Beriou J. M., Autologel Diabetic Foot Ulcer Study Group, A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy/Wound Management 2006 52 6 68 74 2-s2.0-33747621370
61. Gandhi A., Doumas C., O'Connor J. P., Parsons J. R., Lin S. S., The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 2006 38 4 540 546 10.1016/j.bone.2005.10.019
62. Scimeca C. L., Bharara M., Fisher T. K., Kimbriel H., Armstrong D. G., Novel use of platelet-rich plasma to augment curative diabetic foot surgery. Journal of Diabetes Science and Technology 2010 4 5 1121 1126 2-s2.0-79952198038
63. Villela D. L., Santos V. L. C. G., Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors 2010 28 2 111 116 2-s2.0-77949464677 10.3109/08977190903468185
64. Frykberg R. G., Driver V. R., Carman D., Lucero B., Borris-Hale C., Fylling C. P., Rappl L. M., Clausen P. A., Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Ostomy/Wound Management 2010 56 6 36 44 2-s2.0-77958185660
65. Carter M. J., Fylling C. P., Parnell L. K., Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty 2011 11 article e38
66. de Leon J. M., Driver V. R., Fylling C. P., Carter M. J., Anderson C., Wilson J., Dougherty R. M., Fuston D., Trigilia D., Valenski V., Rappl L. M., The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Advances in Skin & Wound Care 2011 24 8 357 368 2-s2.0-81155138392
67. Slesaczeck T., Paetzold H., Nanning T., Reichel A., Barthel A., Bornstein S., Weck M., Autologous derived, platelet-rich plasma gel in the treatment of nonhealing diabetic foot ulcer: a case report. Therapeutic Advances in Endocrinology and Metabolism 2012 3 2 75 78 2-s2.0-84859319995 10.1177/2042018812438213
68. Kessler L., Bilbault P., Ortéga F., Grasso C., Passemard R., Stephan D., Pinget M., Schneider F., Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers a prospective randomized study. Diabetes Care 2003 26 8 2378 2382 2-s2.0-0043025574 10.2337/diacare.26.8.2378 (Pubitemid 36993329)
69. Roeckl-Wiedmann I., Bennett M., Kranke P., Systematic review of hyperbaric oxygen in the management of chronic wounds. The British Journal of Surgery 2005 92 1 24 32 2-s2.0-12444302219 10.1002/bjs.4863 (Pubitemid 40144189)
70. Löndahl M., Landin-Olsson M., Katzman P., Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer. Diabetic Medicine 2011 28 2 186 190 2-s2.0-78651107409 10.1111/j.1464-5491.2010.03185.x
71. Löndahl M., Hyperbaric oxygen therapy as treatment of diabetic foot ulcers. Diabetes/Metabolism Research and Reviews 2012 28 supplement1 78 84
72. Liu R., Li L., Yang M., Boden G., Yang G., Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clinic Proceedings 2013 88 2 166 175 10.1016/j.mayocp.2012.10.021
73. Jeffcoate W. J., Wound healing-a practical algorithm. Diabetes/Metabolism Research and Reviews 2012 28 supplement 1 85 88
74. Gordon K. A., Lebrun E. A., Tomic-Canic M., Kirsner R. S., The role of surgical debridement in healing of diabetic foot ulcers. Skinmed 2012 10 1 24 26 2-s2.0-84857402373
75. van der Plas M. J. A., Baldry M., van Dissel J. T., Jukema G. N., Nibbering P. H., Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP. Diabetologia 2009 52 9 1962 1970 2-s2.0-68449085618 10.1007/s00125-009-1432-6
76. Sherman R. A., Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century. Journal of Diabetes Science and Technology 2009 3 2 336 344 2-s2.0-77952007912
77. Mumcuoglu K. Y., Miller J., Mumcuoglu M., Friger M., Tarshis M., Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). Journal of Medical Entomology 2001 38 2 161 166 2-s2.0-0035291304 (Pubitemid 33613136)
78. Jiang K. C., Sun X. J., Wang W., Excretions/secretions from bacteria-pretreated maggot are more effective against Pseudomonas aeruginosa biofilms. PloS ONE 2012 7 11 e49815 10.1371/journal.pone.0049815
79. Arora S., Baptista C., Lim C. S., Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus. Annals of Clinical Microbiology and Antimicrobials 2011 10, article 6 2-s2.0-79551641566 10.1186/1476-0711-10-6
80. Courtenay M., Church J. C. T., Ryan T. J., Larva therapy in wound management. Journal of the Royal Society of Medicine 2000 93 2 72 74 2-s2.0-0033970237 (Pubitemid 30098623)
81. Dumville J. C., Worthy G., Bland J. M., Cullum N., Dowson C., Iglesias C., Mitchell J. L., Nelson E. A., Soares M. O., Torgerson D. J., Larval therapy for leg ulcers (VenUS II): randomised controlled trial. The British Medical Journal 2009 338 article b773 2-s2.0-63149121187 10.1136/bmj.b773
82. Mumcuoglu K. Y., Clinical applications for maggots in wound care. The American Journal of Clinical Dermatology 2001 2 4 219 227 2-s2.0-0034897162 (Pubitemid 32738664)
83. Li G. Y., Yin J.M., Ding H., Jia W. T., Zhang C. Q., Efficacy of leukocyte-and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model. Journal of Orthopaedic Research 2013 31 6 946 956 10.1002/jor.22299
84. Gottrup F., Jorgensen B., Maggot debridement: an alternative method for debridement. Journal of Plastic Surgery 2011 11 290 300
85. Baer W. S., Treatment of chronic osteomyelitis with the maggot (larve of the blowfly). Journal of Bone and Joint Surgery 1931 13 3 438 475
86. Paul A. G., Ahmad N. W., Lee H., Ariff A. M., Saranum M., Naicker A. S., Osman Z., Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers. International Wound Journal 2009 6 1 39 46 2-s2.0-61849127407 10.1111/j.1742-481X.2008.00564.x
87. Paul A. G., Ahmad N. W., Lee H., Ariff A. M., Saranum M., Naicker A. S., Osman Z., Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers. International Wound Journal 2009 6 1 39 46 2-s2.0-61849127407 10.1111/j.1742-481X.2008.00564.x
88. Dumville J. C., Worthy G., Bland J. M., Cullum N., Dowson C., Iglesias C., Mitchell J. L., Nelson E. A., Soares M. O., Torgerson D. J., Larval therapy for leg ulcers (VenUS II): randomised controlled trial. The British Medical Journal 2009 338 article b773 2-s2.0-63149121187 10.1136/bmj.b773
89. Sherman R. A., Sherman J., Gilead L., Lipo M., Mumcuoglu K. Y., Maggot débridement therapy in outpatients. Archives of Physical Medicine and Rehabilitation 2001 82 9 1226 1229 2-s2.0-0034842473 10.1053/apmr.2001.24300 (Pubitemid 32845886)
90. Soares M. O., Iglesias C. P., Bland J. M., Cullum N., Dumville J. C., Nelson E. A., Torgerson D. J., Worthy G., Cost effectiveness analysis of larval therapy for leg ulcers. The British Medical Journal 2009 338 article b825 2-s2.0-63149131492 10.1136/bmj.b825
91. Nigam Y., Bexfield A., Thomas S., Ratcliffe N. A., Maggot therapy: the science and implication for CAM Part I-history and bacterial resistance. Evidence-Based Complementary and Alternative Medicine 2006 3 2 223 227 2-s2.0-33745712173 10.1093/ecam/nel021
92. Mehta S., Watson J. T., Platelet rich concentrate: basic science and current clinical applications. Journal of Orthopaedic Trauma 2008 22 6 433 438 2-s2.0-52449128520 10.1097/BOT.0b013e31817e793f
93. Heldin C., Westermark B., Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews 1999 79 4 1283 1316 2-s2.0-0032875460 (Pubitemid 29473317)
94. Gandhi A., Bibbo C., Pinzur M., Lin S. S., The role of platelet-rich plasma in foot and ankle surgery. Foot and Ankle Clinics 2005 10 4 621 637 2-s2.0-27744586044 10.1016/j.fcl.2005.06.009 (Pubitemid 41627812)
95. Everts P. A. M., Mahoney C. B., Hoffmann J. J. M. L., Schönberger J. P. A. M., Box H. A. M., van Zundert A., Knape J. T. A., Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 2006 24 3 165 171 2-s2.0-33750540817 10.1080/08977190600821327 (Pubitemid 44669347)
96. Everts P. A. M., Hoffmann J., Weibrich G., Mahoney C. B., Schönberger J. P. A. M., van Zundert A., Knape J. T. A., Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfusion Medicine 2006 16 5 363 368 2-s2.0-33749015447 10.1111/j.1365-3148.2006.00708.x (Pubitemid 44453759)
97. Marx R. E., Platelet-rich plasma: evidence to support its use. Journal of Oral and Maxillofacial Surgery 2004 62 4 489 496 2-s2.0-1842530524 10.1016/j.joms.2003.12.003 (Pubitemid 38451232)
98. Bielecki T. M., Gazdzik T. S., Arendt J., Szczepanski T., Król W., Wielkoszynski T., Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. Journal of Bone and Joint Surgery B 2007 89 3 417 420 2-s2.0-34147192226 10.1302/0301-620X.89B3. 18491 (Pubitemid 46563928)
99. Lacci K. M., Dardik A., Platelet-rich plasma: support for its use in wound healing. Yale Journal of Biology and Medicine 2010 83 1 1 9 2-s2.0-77950524547
100. Heldin C., Westermark B., Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews 1999 79 4 1283 1316 2-s2.0-0032875460 (Pubitemid 29473317)
101. Gandhi A., Bibbo C., Pinzur M., Lin S. S., The role of platelet-rich plasma in foot and ankle surgery. Foot and Ankle Clinics 2005 10 4 621 637 2-s2.0-27744586044 10.1016/j.fcl.2005.06.009 (Pubitemid 41627812)
102. Slesaczeck T., Paetzold H., Nanning T., Reichel A., Barthel A., Bornstein S., Weck M., Autologous derived, platelet-rich plasma gel in the treatment of nonhealing diabetic foot ulcer: a case report. Therapeutic Advances in Endocrinology and Metabolism 2012 3 2 75 78 2-s2.0-84859319995 10.1177/2042018812438213
103. Dougherty E. J., An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Advances in Skin & Wound Care 2008 21 12 568 575 2-s2.0-59649095749
104. Lynch S. E., Williams R. C., Polson A. M., Howell T. H., Reddy M. S., Zappa U. E., Antoniades H. N., A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. Journal of Clinical Periodontology 1989 16 8 545 548 2-s2.0-0024725571
105. LeGrand E. K., Burke J. F., Costa D. E., Kiorpes T. C., Dose responsive effects of PDGF-BB, PDGF-AA, EGF, and bFGF on granulation tissue in a guinea pig partial thickness skin excision model. Growth Factors 1993 8 4 307 314 2-s2.0-0027242159 (Pubitemid 23241835)
106. Heldin C. H., Westermark B., Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews 1999 79 4 1283 1316 2-s2.0-0032875460 (Pubitemid 29473317)
107. Pavlovich C. P., Battiwalla M., Rick M. E., Walther M. M., Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy. Journal of Urology 2001 165 5, article 1617 2-s2.0-0035043412
108. Doupis J., Veves A., Classification, diagnosis, and treatment of diabetic foot ulcers. Wounds 2008 20 5 117 128 2-s2.0-44249123302
109. Alexiadou K., Doupis J., Management of diabetic foot ulcers. Diabetes Therapy 2012 3 1, article 4 10.1007/s13300-012-0004-9
110. Li G. Y., Yin J.M., Ding H., Jia W. T., Zhang C. Q., Efficacy of leukocyte-and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model. Journal of Orthopaedic Research 2013 31 6 949 956 10.1002/jor.22299